Hiroshi Asoh

1.8k total citations
50 papers, 1.5k citations indexed

About

Hiroshi Asoh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroshi Asoh has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 9 papers in Surgery. Recurrent topics in Hiroshi Asoh's work include Lung Cancer Diagnosis and Treatment (29 papers), Lung Cancer Treatments and Mutations (27 papers) and Pleural and Pulmonary Diseases (9 papers). Hiroshi Asoh is often cited by papers focused on Lung Cancer Diagnosis and Treatment (29 papers), Lung Cancer Treatments and Mutations (27 papers) and Pleural and Pulmonary Diseases (9 papers). Hiroshi Asoh collaborates with scholars based in Japan. Hiroshi Asoh's co-authors include Yukito Ichinose, Hideki Yokoyama, Tokujiro Yano, Mitsuo Ohta, Yasaburo Katsuda, Ichiro Yoshino, Nobuyuki Hara, Takashi Inoue, Eiji Takai and Kohsuke Tayama and has published in prestigious journals such as Cancer, British Journal of Cancer and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Hiroshi Asoh

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Asoh Japan 23 1.1k 593 251 160 136 50 1.5k
Paolo Scanagatta Italy 18 690 0.6× 351 0.6× 248 1.0× 158 1.0× 90 0.7× 60 1.1k
Nozomu Machida Japan 20 802 0.7× 819 1.4× 429 1.7× 66 0.4× 255 1.9× 135 1.4k
Mark B. Hazuka United States 23 1.4k 1.3× 638 1.1× 398 1.6× 490 3.1× 234 1.7× 41 2.1k
Yosuke Matsuura Japan 15 592 0.5× 267 0.5× 173 0.7× 128 0.8× 82 0.6× 113 862
D. Antonadou Greece 12 784 0.7× 383 0.6× 144 0.6× 376 2.4× 92 0.7× 32 1.2k
G.P.M. ten Velde Netherlands 15 619 0.6× 452 0.8× 100 0.4× 68 0.4× 75 0.6× 31 921
Mitsuhiro Takemoto Japan 17 533 0.5× 315 0.5× 190 0.8× 136 0.8× 44 0.3× 66 947
Günther Klautke Germany 19 467 0.4× 605 1.0× 456 1.8× 71 0.4× 141 1.0× 69 1.0k
Rie Nakahara Japan 19 752 0.7× 251 0.4× 307 1.2× 269 1.7× 117 0.9× 58 1.2k
John O. Olsen United States 13 293 0.3× 227 0.4× 213 0.8× 348 2.2× 144 1.1× 42 877

Countries citing papers authored by Hiroshi Asoh

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Asoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Asoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Asoh more than expected).

Fields of papers citing papers by Hiroshi Asoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Asoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Asoh. The network helps show where Hiroshi Asoh may publish in the future.

Co-authorship network of co-authors of Hiroshi Asoh

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Asoh. A scholar is included among the top collaborators of Hiroshi Asoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Asoh. Hiroshi Asoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maruyama, Riichiroh, Fumihiro Shoji, Tatsuro Okamoto, et al.. (2005). Triplet Chemotherapy with Cisplatin, Gemcitabine and Vinorelbine for Malignant Pleural Mesothelioma. Japanese Journal of Clinical Oncology. 35(8). 433–438. 13 indexed citations
2.
Okamoto, Tatsuro, Riichiroh Maruyama, Fumihiro Shoji, et al.. (2004). Long-term survivors in stage IV non-small cell lung cancer. Lung Cancer. 47(1). 85–91. 30 indexed citations
3.
Ichinose, Yukito, Yasuro Fukuyama, Hiroshi Asoh, et al.. (2003). Induction chemoradiotherapy and surgical resection for selected stage IIIB non–small-cell lung cancer. The Annals of Thoracic Surgery. 76(6). 1810–1814. 31 indexed citations
5.
Yano, Tokujiro, Hideki Yokoyama, Yasuro Fukuyama, et al.. (1998). Treatment Results of Non-small Cell Lung Cancer in Octogenerians.. Haigan. 38(3). 215–221.
6.
Yano, Tokujiro, Yasuro Fukuyama, Hideki Yokoyama, et al.. (1996). Interleukin-2 receptors in pulmonary adenocarcinoma tissue. Lung Cancer. 16(1). 13–19. 18 indexed citations
7.
Yoshino, Ichiro, Hideki Yokoyama, Tokujiro Yano, et al.. (1996). Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. The Annals of Thoracic Surgery. 62(4). 1021–1025. 84 indexed citations
8.
Ichinose, Yukito, Hiroshi Asoh, Tokujiro Yano, et al.. (1995). Use of a pericardial fat pad flap for preventing bronchopleural fistula: An experimental study focusing on the angiogenesis and cytokine production of the fat pad. Surgery Today. 25(9). 811–815. 19 indexed citations
9.
Takamori, Shinzo, Yukito Ichinose, Hiroshi Asoh, et al.. (1995). Clinicopathologic Characteristics of Stage I Lung Adenocarcinoma in Women.. The Kurume Medical Journal. 42(2). 67–70. 1 indexed citations
10.
11.
Ichinose, Yukito, et al.. (1995). Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer: An analysis in each pathologic stage. Journal of Thoracic and Cardiovascular Surgery. 110(3). 601–605. 160 indexed citations
12.
Ichinose, Yukito, Tokujiro Yano, Hideki Yokoyama, et al.. (1994). Postrecurrent survival of patients with non-small-cell lung cancer undergoing a complete resection. Journal of Thoracic and Cardiovascular Surgery. 108(1). 158–161. 37 indexed citations
13.
Yano, Tokujiro, Hideki Yokoyama, Takashi Inoue, et al.. (1994). The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Journal of Thoracic and Cardiovascular Surgery. 108(4). 680–683. 34 indexed citations
15.
Ichinose, Yukito, Nobuyuki Hara, Mitsuo Ohta, et al.. (1993). Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy in patients with lung cancer. Journal of Thoracic and Cardiovascular Surgery. 105(6). 1041–1046. 18 indexed citations
16.
Ichinose, Yukito, Nobuyuki Hara, Mitsuo Ohta, et al.. (1993). Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer?. Journal of Thoracic and Cardiovascular Surgery. 106(1). 90–94. 63 indexed citations
17.
Ichinose, Yukito, Mitsuo Ohta, Tokujiro Yano, et al.. (1993). Treatment of invasive thymoma with pleural dissemination. Journal of Surgical Oncology. 54(3). 180–183. 30 indexed citations
18.
Hara, Nobuyuki, et al.. (1991). Two Casse of Pulmonary Embolism after Lung Cancer Resection.. Haigan. 31(4). 547–550. 2 indexed citations
19.
Satoh, Kunihiko, Nobuyuki Hara, Yukito Ichinose, et al.. (1991). Treatment and Prognosis of Lung Cancer in the Elderly.. Haigan. 31(7). 1003–1009.
20.
Hara, Nobuyuki, Yukito Ichinose, Hiroshi Asoh, et al.. (1991). Long-Term Survivors in Resected and Nonresected Small Cell Lung Cancer. Oncology. 48(6). 441–447. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026